CTOs on the Move

Owl Insights

www.owlinsights.com

 
Transforming Behavioral Health Care with Data, Evidence and Insights. Owl Insights is the leading provider of precision-guided behavioral health (BH) care management technology.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Owl Insights raised $15M on 09/08/2020

Similar Companies

Lane Regional Medical Center

At Lane Regional Medical Center, we value community and take pride in the role we play as caregivers. It is an honor to say that we serve as the primary healthcare resource for more than 200,000 of our neighbors located throughout Zachary and the surrounding region of Baker, Central, Clinton, Jackson, St. Francisville, New Roads, North Baton Rouge and Southern Mississippi. As part of our continued dedication to serving our community and providing the highest quality of care, we continue to recruit new physicians to the area and to provide access to the very best healthcare services, technologies and programs available in the region.

MIDWEST OPTICAL SYSTEMS

MIDWEST OPTICAL SYSTEMS, INC. is a Palatine, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Inteprod

Inteprod LLC is a Norristown, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NinePoint Medical

NinePoint Medical is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Portola

Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.